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Abstract
Aim: To determine the effects of cigarette smoke (CS) exposure on the expression/activation of mitogen-activated protein kinases (MAPKs)
(extracellular signal-regulated kinase [ERK1/2], p38-kinase [p38] and c-Jun NH2-terminal protein kinase [JNK]), norepinephrine (NE) levels
and myocardial structure and function.
Methods: Rats were randomised to two groups: CS-exposed (n=12) or room air (CON) (n=10). After 5 weeks, the animals underwent
echocardiography with pulse-wave Doppler flow measurements. Hearts were removed for microscopy and Western blot analysis.
Results: CS exposure was associated with significant increases in NE urinary levels and larger ventricular dimensions (mm) (CON=left
ventricular end diastolic dimension [LVEDD] 7.99±0.10, LV end systolic dimension [LVESD] 4.55±0.20, CS=LVEDD 8.3±0.10, LVESD
5.3±0.09, p=0.026, p=0.003). There was also evidence of systolic dysfunction in the CS-exposed group compared to the CON group
(fractional shortening %, CON=43±2, CS=36± .09, p=0.010). In CS-exposed hearts, significant increases in phosphorylated p38/total p38
(0.975±0.05) and phosphorylated ERK1/2/totalERK1/2 (1.919±0.050) were found compared to CON hearts (0.464±0.008, 0.459±0.050,
respectively). No significant differences were found in JNK levels between the groups.
Conclusions: Increased NE levels and MAPK activation are associated with CS-related left ventricular remodelling.
Published by Elsevier B.V. on behalf of European Society of Cardiology.
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1. Introduction
Heart disease that results from primary as well as
environmental cigarette smoke (CS) exposure more than
likely develops as a result of a complex interaction among
the many constituents in cigarette smoke. CS contains over
4000 different constituents, one of which is nicotine [1].
Many of the adverse cardiovascular effects of CS have been
attributed to nicotine. Nicotine administration is associated
with changes in cardiac output and heart rate; however, the
effect of nicotine on the initiation and progression of CS-
mediated cardiovascular events remains controversial [1–3].
Furthermore, small clinical trials of nicotine replacement
therapies have not shown an increased cardiovascular risk,
even in patients with cardiovascular disease, suggesting the
need to consider CS as a whole rather than nicotine alone
[4,5]. Using nicotine alone may lead to inaccurate informa-
tion regarding the pathophysiological effects of CS.
Others have examined the effects of 4–5 weeks of CS
exposure on echocardiographic-derived parameters and
found increased left ventricular end diastolic and systolic
dimensions, indicating some degree of left ventricular (LV)
remodelling [6,7]. To our knowledge, no reports have
examined the effects of CS on both myocardial structure
and signal transduction pathways such as mitogen-activated
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protein kinases (MAPKs), which govern cell survival and
growth in the myocardium. There is evidence from others (in
humans and in animal models) that CS is associated with
increased levels of norepinephrine (NE) and tumour necrosis
factor α [8,9]. These latter extracellular signals activate
MAPKs, such as extracellular-regulated kinase (ERK1/2),
p38 kinase (p38) and c-Jun NH2-terminal protein kinase
(JNK). In the myocardium, activation of MAPKs such as
ERK1/2, p38 and JNK plays a key role in the pathogenesis of
many processes, such as hypertrophy, heart failure and
reperfusion injury [10]. Therefore, the primary objectives of
this investigation were to determine in adult male rats the
expression/activation of MAPKs that are involved in the
regulation of cell growth, cell differentiation and cell death
(ERK1/2, p38, JNK) and determine if increased expression
of MAPKs parallels CS-induced histological and structural
changes in the myocardium (as assessed via electron
microscopy and echocardiography, respectively). Further-
more, we measured urinary levels of NE, since CS exposure
in humans is associated with increased NE levels and NE is
associated with the activation of MAPKs. It was hypothe-
sized that CS exposure would significantly alter left
ventricular structure and be associated with systolic and
diastolic dysfunction as well as activation of MAPKs.
2. Methods
2.1. Groups and treatment
All experiments were performed in accordance with the
Guide for the Care and Use of Laboratory Animals published
by the U.S. National Institutes of Health (NIH Publication No.
85-23, revised 1996) and were approved by the Institutional
Animal Care and Use Committee. After arrival and a brief
acclimation period, age-matched male Sprague–Dawley rats
(beginning body weights 210–260 g) were randomly divided
into the following groups: control (CON) animals (n=10) not
exposed to cigarette smoke, and CS-exposed animals (n=12)
exposed to 45 min of CS twice a day for 5 weeks.
Similar to other investigators, we used a smoke exposure
system (University of Kentucky Tobacco and Health
Research Institute smoking machine) which exposes rats to
mainstream smoke (nose-only exposure) from a cigarette
[11,12]. This system has been extensively used to study
smoking-related diseases, and it allows for exposure to CS in
conscious, restrained rats. As noted above, rats in the CS
group received CS twice daily for 5 weeks. The University of
Kentucky reference (2R1) cigarettes were used in all
experiments. The 2R1 cigarette has a tar yield of 34.3 mg
and nicotine yield of 2.16 mg. As a point of reference, the
average yield of a cigarette marketed in the U.S. in 1994 was
12.1 mg tar and between 1.72 and 1.89 mg nicotine.
Cigarettes were placed into the cigarette puffer, and a
peristaltic pump was used to generate puffs at a frequency
of 1/min, durations of 2.4 s and puff volumes of 38 ml [11].
Animals received two 45- to 60-min CS sessions per day.
Urinary cotinine levels were measured at the end of the 5-
week protocol and were quantified using an enzyme-linked
radioimmunoassay (ELISA) (Cozart Bioscience, Oxford-
shire, UK). A 24-hour urine creatinine measure was also
taken, and cotinine levels were normalized to urinary
creatinine levels. In the CON group, the cotinine level was
15±5 (ng/mmol/creatinine), and it was 1102±306 (ng/mmol/
creatinine) in the CS group. These cotinine levels were in the
range of those reported in human active smokers (i.e., those
who smokedN10 cigarettes/day) [13].
2.2. Urinary norepinephrine
Norepinephrine (NE) levels can be influenced by physical
stress, such as handling and anaesthesia. Therefore, 2 days
prior to sacrifice, both groups of animals were placed into
metabolic cages, and urine was collected for a 24-hour
period. Urine was collected into tubes containing 6 M
hydrochloric acid. The total 24-hour volume was measured,
and 1-ml aliquots were stored at −20 °C until assay. NE was
measured using an ELISA (Rocky Mountain Diagnostics,
Colorado Springs, CO). All samples were run in duplicate.
2.3. Echocardiography
All echocardiograms were performed as previously
described by our laboratory and according to the American
Society of Echocardiography guidelines [14,15]. Echocardio-
grams were performed by the same experienced sonographer
using the Sequoia C256 Echocardiography System (Acuson
Corporation,Mountain View, CA) and a 15.0MHz transducer.
Before the procedure, animals were anaesthetized with an
initial dose of methoxyflurane, and sedation was maintained
thereafter via intubation with 1% isoflurane, using a Harvard
small-animal ventilator (respiratory rate 80 breaths per minute,
respiratory volume 2.5 ml). Body temperature was monitored
using a rectal thermistor and maintained at 37 °C using a
warming plate perfused with a water circulating bath. The
transducer was placed on the left thorax, and M-mode and 2-
dimensional echocardiography images were obtained in the
parasternal long- and short-axis views by directing the
ultrasound beam at the mid-papillary muscle level. The
measurements listed below were obtained after well-defined,
continuous interface of the anterior and posterior walls were
visualized. All parameters were measured with electronic
calipers, and mean calculations were obtained from three or
more consecutive cardiac cycles. For all animals, three to four
beats were recorded using the same transducer position.
Fractional shortening (FS) and relative wall thickness (RWT)
were calculated as previously described. Using pulse-wave
Doppler echocardiography, we also measured signals from the
left ventricular inflow and outflow track and obtained indices
of diastolic function such as: isovolumic relaxation time
(IVRT) (time between the closure of the aortic valve [S2] and
opening of the mitral value), deceleration time (DT), and E/A
ratio (the E wave represents early rapid filling of the ventricle;
1058 L. Gu et al. / European Journal of Heart Failure 10 (2008) 1057–1064
the Awave represents late filling of the ventricle).Mean values
were used for statistical analysis.
2.4. Tissue collection
After sacrifice, the myocardium was removed and rinsed
in normal saline. A small (b1-mm) section was removed and
fixed in 2.5% glutaraldehyde-buffered (pH 7.4) solution.
Two more small sections were cut, and one was flash-frozen
and stored at −80 °C for Western blot analysis.
2.5. Electron microscopy
One-mm sections were subsequently postfixed in osmium,
dehydrated in acetone and flat-embedded in epoxy resin.
Ultrathin sections were cut and then examined with a Phillips
EM-400 electron microscope (Phillips Electronic Instruments,
Mount Vernon, NY). A pathologist blinded to the experiment
groups examined micrographs from at least 2 blocks (10
random electron micrographs) for ultrastructural changes.
2.6. MAPK Western blot analysis
Using methods previously described by our laboratory,
immunoblots were performed using 40-μg total protein
homogenates [16]. Briefly, protein homogenates were
prepared from the left ventricle, and total protein concentra-
tions were determined by Lowry (Bio-Rad) assay. Equal
amounts of protein (40 μg) were loaded onto a 10% SDS-
PAGE, subjected to gel electrophoresis, and electroblotted
onto nitrocellulose membranes that were blocked with milk,
washed and then incubated with primary antibody. Primary
antibodies employed included: rabbit polyclonal anti-phos-
pho-p38 MAPK, anti-phospho-ERK1/2, anti-phospho-JNK
anti-P38, anti-ERK1/2 and anti-JNK (Cell Signaling Tech-
nology, Inc., Boston, MA). Membranes were extensively
washed and then incubated with horseradish peroxidase-
conjugated anti-rabbit secondary antibody (Jackson Immu-
noResearch, West Grove, PA). Bands were visualized with
the ECL system (Amersham, Little Chalfont, UK) and
quantified with Chemi Doc XRS (Bio-Rad) applying
Quantity One software.
Table 1
Body weight, heart weight and urinary norepinephrine levels
BW (gm) HW-to-BW (g/g) HW-to-Tibia
(g/cm)
Norepinephrine
(pg/100 μl)
CON 347±5.8 3.00± .001 0.28± .004 10±5
CS 365±5.7 3.24± .06⁎ 0.31± .023 1270±33⁎
Values are mean±SEM, BW—body weight, HW-to-BW ratio—heart
weight to BW ratio. ⁎Indicates significantly greater than CON (p=0.01).
Fig. 1. Representative electron micrographs from control (panel A) and CS-exposed animals (panel B).
Table 2
Echocardiographic parameters
Control CS p
Heart rate (bpm) 341±11 316±6 0.083
LVEDD (mm) 7.99±0.1 8.3±0.10 0.026
LVESD (mm) 4.55±0.2 5.3±0.09 0.003
LVPWD (mm) 1.40±0.06 1.40±0.07 0.990
LVPWS (mm) 2.40±0.04 2.18±0.14 0.200
FS (%) 43±2.1 36±0.9 0.010
LV mass (g) 0.67± .03 0.72± .04 0.320
RWT 0.35± .01 0.33± .01 0.430
Abbreviations used: FS—fractional shortening, left ventricle (LV) end diastolic
dimension (LVEDD), LVend systolic dimension (LVESD), LV posterior wall
thickness in diastole (LVPWD) and LV posterior wall thickness in systole
(LVPWS), relative wall thickness (RWT=2×LVPWD/EDD). Data are
expressed as mean±SEM.
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2.7. Statistical analysis
All data are expressed as the mean±SEM. Data were
compared using a one-way analysis of variance (ANOVA).
When a significant F ratio (pb0.05) was found, group
comparisons were made using a Fisher's post-hoc procedure
for multiple comparisons (Sigmastat v 3.5, SYSTAT Soft-
ware, Richmond, CA).
3. Results
No differences were found between groups in the
ending body weight (BW) or heart weight (HW)-to-tibia
ratio (Table 1). The HW-to-BW ratio, however, was
significantly greater in the CS group than in the CON
group (Table 1). Urinary NE levels were also significantly
increased in CS-exposed animals compared to CON
animals (p=0.004).
Fig. 1 shows representative electron micrographs of the
ultrastructure of the LV muscle from CON and CS-exposed
rats. A pathologist blinded to group assignment examined
and scored sections for the general appearance of the tissue,
changes in intracellular organelles (such as the mitochondria
and sarcoplasmic reticulum), and evidence of cell loss or
myofibril disarray. No significant ultrastructural changes
were found in either group.
Significant increases in LVEDD and LVESD were found
in the CS group compared to the CON group (Table 2). Left
ventricular posterior wall thickness in diastole (LVPWD), left
ventricular posterior wall thickness at systole (LVPWS) and
RWT were not significantly different between the groups;
Fig. 2. Representative pulse-wave Doppler echocardiograms from control
(panel A) and CS-exposed (panel B) animals.
Fig. 3. Indices of diastolic function in control and cigarette smoke exposed
animals. Data are expressed as mean±SEM. Abbreviations used: DT-
deceleration time and IVRT-isovolumic relaxation time. ⁎Indicates sig-
nificantly different from control (p=0.01).
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however, FS was significantly lower in the CS group than in
the CON group (Table 2). Using pulse-wave Doppler
imaging, we found well-defined signals in 94% of the
animals (representative images are shown in Fig. 2). We
found a significant increase in the E/A ratio in the CS group
compared to the CON group (Fig. 3). IVRT and DTwere not
significantly different between groups (Fig. 3).
3.1. Western blotting of MAPKs
Protein levels of total p38, ERK1/2, JNK, P-p38, P-ERK1/
2 and P-JNK were determined usingWestern blotting. Levels
were expressed as the ratio of phosphorylated (P)-to-total
protein levels. The levels of P-p38 and P-ERK1/2 were
significantly greater in the CS-exposed hearts compared to
the CON hearts (Fig. 4, Panels A and B) (pb0.01). No
significant differences were found in JNK levels between the
groups (Fig. 4, Panel C).
4. Discussion
This is the first study to demonstrate that CS-induced
ventricular remodelling is linked to activation of MAPKs.
Our data also suggest that CS smoke exposure is associated
with systolic dysfunction and increased adrenergic drive.
Collectively, these data support the involvement of MAPKs
in CS-induced remodelling and cardiac dysfunction.
To date, there have been few studies examining the effects
of CS on the myocardium, and to our knowledge no
investigations have examined cell mechanisms that are
linked to the toxic effects of CS on the myocardium.
Although CS affects the entire cardiovascular system, it has
been generally accepted that the most adverse effects were
on the vasculature and included endothelial dysfunction and
accelerated atherosclerosis [17]. However, a landmark
prospective clinical study by Hartz and colleagues in 1984
established in men younger than 55 years of age (without
Fig. 4. Activation of MAPKs. Levels were expressed as the ratio of phosphorylated (P)-to-total protein levels. Data are expressed as mean±SEM. ⁎Indicates
significantly different from control (pb0.01). Representative Western blots.
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evidence of coronary artery disease or history of myocardial
infarction) that CS exposure was associated with diffuse
ventricular hypokinesis [18]. The associations between CS
and reduced left ventricular function and greater left
ventricular mass have been re-affirmed in more recent
large population-based epidemiological studies using mag-
netic resonance imaging to evaluate myocardial structure and
function [19,20]. These data are further substantiated by our
findings and those of others, which demonstrate that CS
exposure is associated with ventricular remodelling [6,7].
Our findings of an increase in EDD and ESD and a decrease
in FS in CS-exposed animals are similar to others, who have
shown that 4 months of CS exposure is associated with cardiac
remodelling and systolic dysfunction [6,7]. Changes in
diastolic function after CS exposure have been equivocal in
animal models and in human beings. Doppler-derived
echocardiography parameters that reflect diastolic dysfunction
include an increase in the E/A ratio and prolonged DT and
IVRT values. In the present study, we found a significant
increase in the E/A ratio in the CS group compared to CON
group; however, even though DT and IVRTwere increased in
the CS group compared to CON, these differences were not
significant. Following 4 months of CS exposure, Castardeli et
al. found no change in the E/A ratio between CON and CS-
exposed rats [6,7]. In human subjects, investigators have
examined the acute one-time effect of CS exposure on diastolic
function [21]. Alam et al. found evidence of diastolic
dysfunction in healthy subjects immediately after smoking
one cigarette [21]. In a similar study, 30 min after subjects
smoked one cigarette, Karakaya et al. found evidence of
diastolic dysfunction in subjects with coronary artery disease,
while no significant changes were found in healthy subjects
[22]. To our knowledge, there are no studies examining longer
durations of CS exposure on diastolic function in human
subjects. It would be interesting to determine if CS exposure
alters intracellular organelles (e.g., sarcoplasmic reticulum) or
molecular events (sarcoplasmic reticulum uptake of calcium)
that govern diastolic function.
In our study, 5 weeks of CS exposure was associated with
increased urinary NE levels. CS is associated with increased
sympathetic activation and NE levels according to Cryer et al.
[8] and Narkiewicz et al. [23]. Via activation of different
adrenergic receptor (AR) subtypes, NE can be associated with
either myocyte hypertrophy (α1A AR) or apoptosis (β1 AR)
[24]. Activation of the α1A AR is also associated with
increased ERK1/2 activation [25].We did not examine cardiac
tissue for evidence of apoptosis or myocyte hypertrophy (e.g.,
increased cell size or protein synthesis).
Our data clearly indicate that CS activates MAPKs such as
p38 and ERK1/2. Our findings concur with previous studies,
which have established a role for activation of MAPK
signalling in the pathogenesis of CS-induced lung injury
(emphysema) and inflammation [26,27]. Furthermore, others
have shown that CS-induced phosphorylation of ERK1/2
precedes the activation of protooncogenes that belong to the
AP-1 transcription family (e.g., fos and jun). Importantly, genes
that encode for growth factors (e.g., insulin-like growth factor)
and extracellular matrix metalloproteinases (MMPs) have an
AP-1 site in their promoter or enhancer region [28]. MMPs are
proteinases that can degrade almost all of the extracellular
matrix proteins. In terms of the myocardium, increased MMP
activity is associatedwith breakdown of the supporting fibrillar
collagen network. Loss of the supporting fibrillar collagen
network, along with loss of the collagen tethers, leads to
myocyte slippage, ventricular wall thinning, and enlargement
[29].Mercer et al. [26] andNing et al. [30] have demonstrated a
strong causal role for ERK1/2 signalling and the activation of
MMP in pulmonary epithelial cells and the consequent
development of emphysema, a disease characterized by loss
of alveolar attachments and parenchymal destruction.
We also found that 5 weeks of CS exposure was associated
with increased p38 phosphorylation. p38 has also been
referred to as a cytokine-suppressive anti-inflammatory drug-
binding protein [10]. p38 is strongly activated by cytokines,
such as TNFα, and other cellular stressors, such as oxidative
stress and hyperosmolarity. Using an animal model, Liu et al.
[31] and Li et al. [32] have shown that inhibition of p38 (in
particular the α isoform) protects the heart against remodel-
ling following myocardial infarction. In addition, Li et al.
demonstrated that there were fewer infiltrating macrophages
and apoptotic cells after animals were treated with the p38
inhibitor SD-282. Collectively, the latter data suggest that
activation of the p38 pathway is a key mechanism in
ischaemia-induced myocardial dysfunction. Considering CS
exposure is associated with increased TNFα and oxidative
stress [9,33], it is not surprising that we found increases in
p38 phosphorylation. Using human pulmonary artery
endothelial cells in culture, Low et al. [34] demonstrated
that p38 mediates CS-induced endothelial permeability. It
will be important to conduct future experiments to determine
if there is evidence of apoptosis and inflammation and if a
longer duration of CS exposure is associated with more
severe changes, as well as activation of JNK.
The way in which CS activates both the p38 and ERK1/2
MAPK cascades remains unknown and could potentially
occur at multiple levels: via stimulation/release hormones or
by activation of upstream kinases, such as MAPK kinase
kinase (MEKK) or MAPK kinases (MEK). As noted above,
NE is associated with activation of the MAPK cascade (e.g.,
ERK1/2). CS exposure is also associated with increased
cytokine levels, such as TNFα, which in turn is associatedwith
activation of p38 MAPKs. However, it is well established that
CS contains oxidants and is a potent stimulator of oxidative
stress. Therefore, it is also possible that CS may (via the
generation of oxidants) directly activate upstream kinases,
such asMEKKorMEK [35,36].We did not find an increase in
JNK after 5 weeks of CS exposure. Perhaps the preferential
activation of p38 and ERK1/2 are related to either the duration
of CS exposure or overall level of oxidative stress.
We did not find any significant changes in the appearance
of the sarcomeres, myofilaments, or mitochondria between
groups upon ultrastructural analysis. This is in contrast to
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Zornoff et al. [37], who reported that 30 days of environ-
mental tobacco smoke exposure in male Wistar rats was
associated with disorganization of the myofibrils and
mitochondrial swelling. In the Zornoff et al. study, animals
were exposed to 10 cigarettes in the morning and then again
in the afternoon. In our protocol, animals were exposed to
45 min of mainstream smoke (approximately 2–3 cigarettes)
twice a day. The earlier investigators did not report cotinine
levels; therefore, it is difficult to compare our two studies in
terms of the amount of smoke exposure. However, the
animals in the Zornoff protocol more than likely received
more smoke exposure, perhaps explaining their morpholo-
gical tissue findings. In addition, the type of cigarette (2R1)
we used has a greater tar and nicotine content compared to
the type of cigarette used by others [37]. Also, as noted in the
methods section, the tar and nicotine content of the R21 is
greater than conventional cigarettes available to the public.
However, using this type of cigarette, aswell as an intermittent,
short-term (5-week) exposure protocol in a rodent model, our
urinary cotinine levels (1102±306 ng/mmol/creatinine)
approximate those reported in human active smokers (i.e.,
those who smoked N10 cigarettes/day) [13].
4.1. Study limitations
There are several limitations in this study. CS induces the
secretion of different types of circulating neurohumoral
stimuli, such as NE, that are linked to MAPK activation. In
our intermittent rodent CS model, we found large increases
in urinary NE. However, we did not assay for increases in
other stimuli, such as TNFα, which others have found to be
increased in smoking human beings [38] and animal models
exposed to CS [39]. Similar to NE, TNFα is a potent
activator of MAPKs; therefore, in future studies, it would be
important to determine if TNFα serum and/or myocardial
tissues levels are increased after CS. Second, because we
measured MAPK activation and structural and functional
parameters of LV remodelling at the same time point and did
not attempt to inhibit MAPK activation, we cannot conclude
that CS-induced activation of MAPK leads to cardiac
remodelling. Using cultured human pulmonary artery
endothelial cells, Low et al. found that the addition of a
p38 MPK-selective inhibitor (SB203580) prevented CS-
induced p38 activation and the development of endothelial
damage (i.e., increased endothelial cell permeability) [34].
p38 MAPK inhibitors are available and have been associated
with positive and protective effects in animal models of
inflammation [40] and myocardial injury [32]. Findings of
the present study could be confirmed in future studies
incorporating the use of MAPK inhibitors.
5. Conclusion
In conclusion, this study identified that 5 weeks of
mainstream CS exposure is associated with LV remodelling,
systolic dysfunction and activation of p38 and ERK1/2
MAPKs. MAPKs govern cell survival and growth in the
myocardium, and others have shown that activation of
MAPKs plays a key role in the pathogenesis of hypertrophy,
heart failure and ischaemia/reperfusion injury. Moreover, in
other tissues, CS activation of the MAPK signalling cascade
is considered to be a key mechanistic event leading to cell
injury, altered cell differentiation and inflammation [27].
Therefore, activation of MAPKs may represent an important
event in CS-induced cardiotoxicity.
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